{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:21Z","timestamp":1791290661543,"version":"4.3.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00296-019-04251-6","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T22:36:02Z","timestamp":1550010962000},"page":"781-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Role of inflammation in the pathogenesis and treatment of fibromyalgia"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-5969","authenticated-orcid":false,"given":"Ilke","family":"Coskun Benlidayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"4251_CR1","first-page":"736","volume-title":"Rheumatology","author":"DJ Clauw","year":"2019","unstructured":"Clauw DJ (2019) Fibromyalgia and related syndromes. In: Hochberg MC, Gravallese EM, Silman AJ, Smo\u015fen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 7th edn. Elsevier, Philadelphia, pp\u00a0736\u2013745","edition":"7"},{"key":"4251_CR2","first-page":"195","volume":"32","author":"F Mastrangelo","year":"2018","unstructured":"Mastrangelo F, Frydas I, Ronconi G, Kritas SK, Tettamanti L, Caraffa A, D Ovidio C, Younes A, Gallenga CE, Conti P (2018) Low-grade chronic inflammation mediate by mast cells in fibromyalgia: role of IL-37. J Biol Regul Homeost Agents 32:195\u2013198","journal-title":"J Biol Regul Homeost Agents"},{"key":"4251_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00296-018-4138-6","volume":"38","author":"I Coskun Benlidayi","year":"2018","unstructured":"Coskun Benlidayi I (2018) Fibromyalgia as a challenge for patients and physicians. Rheumatol Int 38:2345. \n                    https:\/\/doi.org\/10.1007\/s00296-018-4138-4136","journal-title":"Rheumatol Int"},{"key":"4251_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10067-015-3024-9","volume":"35","author":"E Kozanoglu","year":"2016","unstructured":"Kozanoglu E, Coskun Benlidayi I, Eker Akilli R, Tasal A (2016) Is there any link between joint hypermobility and mitral valve prolapse in patients with fibromyalgia syndrome? Clin Rheumatol 35:1041\u20131044. \n                    https:\/\/doi.org\/10.1007\/s10067-015-3024-3029","journal-title":"Clin Rheumatol"},{"key":"4251_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jprot.2018.07.009","volume":"186","author":"JA Ram\u00edrez-Tejero","year":"2018","unstructured":"Ram\u00edrez-Tejero JA, Mart\u00ednez-Lara E, Rus A, Camacho MV, Del Moral ML, Siles E (2018) Insight into the biological pathways underlying fibromyalgia by a proteomic approach (. J Proteomics 186:47\u201355. \n                    https:\/\/doi.org\/10.1016\/j.jprot.2018.07.009","journal-title":"J Proteomics"},{"key":"4251_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","volume":"338","author":"KA Sluka","year":"2016","unstructured":"Sluka KA, Clauw DJ (2016) Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338:114\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2016.06.006","journal-title":"Neuroscience"},{"key":"4251_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00281-018-0672-2","volume":"40","author":"G Littlejohn","year":"2018","unstructured":"Littlejohn G, Guymer E (2018) Neurogenic inflammation in fibromyalgia. Semin Immunopathol 40:291\u2013300. \n                    https:\/\/doi.org\/10.1007\/s00281-018-0672-2","journal-title":"Semin Immunopathol"},{"key":"4251_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1573397112666160919120530","volume":"13","author":"S Metyas","year":"2017","unstructured":"Metyas S, Rezk T, Arkfeld D, Leptich T (2017) Autoinflammation and immunomodulation in inflammatory fibromyalgia syndrome- a review. Curr Rheumatol Rev 13:98\u2013102. \n                    https:\/\/doi.org\/10.2174\/1573397112666160919120530","journal-title":"Curr Rheumatol Rev"},{"key":"4251_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","volume":"242","author":"D Kadetoff","year":"2012","unstructured":"Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E (2012) Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels (. J Neuroimmunol 242:33\u201338. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2011.10.013","journal-title":"J Neuroimmunol"},{"key":"4251_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.02.002","volume":"280","author":"E Kosek","year":"2015","unstructured":"Kosek E, Altawil R, Kadetoff D, Finn A, Westman M, Le Ma\u00eetre E, Andersson M, Jensen-Urstad M, Lampa J (2015) Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain-interleukin-8 in fibromyalgia and interleukin-1 \u03b2 in rheumatoid arthritis. J Neuroimmunol 280:49\u201355. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2015.02.002","journal-title":"J Neuroimmunol"},{"key":"4251_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","volume":"290","author":"D Mendieta","year":"2016","unstructured":"Mendieta D, De la Cruz-Aguilera DL, Barrera-Villalpando MI, Becerril-Villanueva E, Arreola R, Hern\u00e1ndez-Ferreira E, P\u00e9rez-Tapia SM, P\u00e9rez-S\u00e1nchez G, Garc\u00e9s-Alvarez ME, Aguirre-Cruz L, Velasco-Vel\u00e1zquez MA, Pav\u00f3n L (2016) IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J Neuroimmunol 290:22\u201325. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2015.11.011","journal-title":"J Neuroimmunol"},{"key":"4251_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/10582452.2012.704141","volume":"20","author":"D Malhotra","year":"2012","unstructured":"Malhotra D, Saxena AK, Dar SA, Kumar V, Nasare N, Tripathi AK, Banerjee BD (2012) Evaluation of cytokine levels in fibromyalgia syndrome patients and its relationship to the severity of chronic pain. J Musculoskelet Pain 20:164\u2013169. \n                    https:\/\/doi.org\/10.3109\/10582452.2012.704141","journal-title":"J Musculoskelet Pain"},{"key":"4251_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000341664","volume":"19","author":"ME Bote","year":"2012","unstructured":"Bote ME, Garc\u00eda JJ, Hinchado MD, Ortega E (2012) Inflammatory\/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 19:343\u2013351. \n                    https:\/\/doi.org\/10.1159\/000341664","journal-title":"Neuroimmunomodulation"},{"key":"4251_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/CIA.S60330","volume":"9","author":"M Imamura","year":"2014","unstructured":"Imamura M, Targino RA, Hsing WT, Imamura S, Azevedo RS, Boas LS, Tozetto-Mendoza TR, Alfieri FM, Filippo TR, Battistella LR (2014) Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin Interv Aging 9:939\u2013944. \n                    https:\/\/doi.org\/10.2147\/CIA.S60330","journal-title":"Clin Interv Aging"},{"key":"4251_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. \n                    https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4251_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","volume":"19","author":"AM Manicone","year":"2008","unstructured":"Manicone AM, McGuire JK (2008) Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19:34\u201341","journal-title":"Semin Cell Dev Biol"},{"key":"4251_CR17","first-page":"51","volume-title":"Essentials of pathophysiology","author":"CM Porth","year":"2011","unstructured":"Porth CM (2011) Inflammation, the inflammatory response and fever. In: Porth CM (ed) Essentials of pathophysiology, 3rd\u00a0edn. Wolters Kluwer Health|Lippincott Williams & Wilkins, China, pp\u00a051\u201372","edition":"3"},{"key":"4251_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/papr.12252","volume":"16","author":"MF Bjurstrom","year":"2016","unstructured":"Bjurstrom MF, Giron SE, Griffis CA (2016) Cerebrospinal fluid cytokines and neurotrophic factors in human chronic pain populations: a comprehensive review. Pain Pract 16:183\u2013203. \n                    https:\/\/doi.org\/10.1111\/papr.12252","journal-title":"Pain Pract"},{"key":"4251_CR19","doi-asserted-by":"publisher","first-page":"e0143856","DOI":"10.1371\/journal.pone.0143856","volume":"10","author":"N Christidis","year":"2015","unstructured":"Christidis N, Ghafouri B, Larsson A, Palstam A, Mannerkorpi K, Bileviciute-Ljungar I, L\u00f6fgren M, Bjersing J, Kosek E, Gerdle B, Ernberg M (2015) Comparison of the levels of pro-inflammatory cytokines released in the vastus lateralis muscle of patients with fibromyalgia and healthy controls during contractions of the quadriceps muscle\u2014a microdialysis study. PLoS One 10:e0143856. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0143856","journal-title":"PLoS One"},{"key":"4251_CR20","doi-asserted-by":"publisher","first-page":"e65033","DOI":"10.1371\/journal.pone.0065033","volume":"8","author":"J Feng","year":"2013","unstructured":"Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X, Gao H, Ouyang C, Dery KJ, Le K, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE (2013) Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS One 8:e65033. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0065033","journal-title":"PLoS One"},{"key":"4251_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/art.33338","volume":"64","author":"SB Smith","year":"2012","unstructured":"Smith SB, Maixner DW, Fillingim RB, Slade G, Gracely RH, Ambrose K, Zaykin DV, Hyde C, John S, Tan K, Maixner W, Diatchenko L (2012) Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 64:584\u2013593. \n                    https:\/\/doi.org\/10.1002\/art.33338","journal-title":"Arthritis Rheum"},{"key":"4251_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/acr.22639","volume":"68","author":"E Iacob","year":"2016","unstructured":"Iacob E, Light AR, Donaldson GW, Okifuji A, Hughen RW, White AT, Light KC (2016) Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample. Arthritis Care Res (Hoboken) 68:132\u2013140. \n                    https:\/\/doi.org\/10.1002\/acr.22639","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4251_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","volume":"84","author":"A Ranzolin","year":"2016","unstructured":"Ranzolin A, Duarte AL, Bredemeier M, da Costa Neto CA, Ascoli BM, Wollenhaupt-Aguiar B, Kapczinski F, Xavier RM (2016) Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia\u2014a controlled cross-sectional study. Cytokine 84:25\u201328. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2016.05.011","journal-title":"Cytokine"},{"issue":"6 Suppl 79","key":"4251_CR24","first-page":"S60-63","volume":"31","author":"AP Pernambuco","year":"2013","unstructured":"Pernambuco AP, Schetino LP, Alvim CC, Murad CM, Viana RS, Carvalho LS, Reis D (2013) Increased levels of IL-17A in patients with fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79):S60-63","journal-title":"Clin Exp Rheumatol"},{"key":"4251_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00296-012-2538-6","volume":"33","author":"Y Xiao","year":"2013","unstructured":"Xiao Y, Haynes WL, Michalek JE, Russell IJ (2013) Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 33:1259\u20131264. \n                    https:\/\/doi.org\/10.1007\/s00296-012-2538-6","journal-title":"Rheumatol Int"},{"key":"4251_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1472-6890-12-25","volume":"12","author":"FG Behm","year":"2012","unstructured":"Behm FG, Gavin IM, Karpenko O, Lindgren V, Gaitonde S, Gashkoff PA, Gillis BS (2012) Unique immunologic patterns in fibromyalgia. BMC Clin Pathol 12:25. \n                    https:\/\/doi.org\/10.1186\/1472-6890-12-25","journal-title":"BMC Clin Pathol"},{"key":"4251_CR27","doi-asserted-by":"publisher","first-page":"938576","DOI":"10.1155\/2014\/938576","volume":"2014","author":"J Sturgill","year":"2014","unstructured":"Sturgill J, McGee E, Menzies V (2014) Unique cytokine signature in the plasma of patients with fibromyalgia. J Immunol Res 2014:938576. \n                    https:\/\/doi.org\/10.1155\/2014\/938576","journal-title":"J Immunol Res"},{"key":"4251_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC (2016) Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther 356:664\u2013672. \n                    https:\/\/doi.org\/10.1124\/jpet.115.230060","journal-title":"J Pharmacol Exp Ther"},{"key":"4251_CR29","first-page":"81","volume":"105","author":"C Iannuccelli","year":"2017","unstructured":"Iannuccelli C, Guzzo MP, Atzeni F, Mannocci F, Alessandri C, Gerardi MC, Valesini G, Di Franco M (2017) Pain modulation in patients with fibromyalgia undergoing acupuncture treatment is associated with fluctuations in serum neuropeptide Y levels. Clin Exp Rheumatol 105:81\u201385","journal-title":"Clin Exp Rheumatol"},{"key":"4251_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/smi.2648","volume":"32","author":"AG Taylor","year":"2016","unstructured":"Taylor AG, Fischer-White TG, Anderson JG, Adelstein KE, Murugesan M, Lewis JE, Scott MM, Gaykema RP, Goehler LE (2016) Stress, inflammation and pain: a potential role for monocytes in fibromyalgia-related symptom severity. Stress Health 32:503\u2013513. \n                    https:\/\/doi.org\/10.1002\/smi.2648","journal-title":"Stress Health"},{"key":"4251_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","volume":"12","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Kishioka S (2012) Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 12:55\u201361. \n                    https:\/\/doi.org\/10.1016\/j.coph.2011.10.007","journal-title":"Curr Opin Pharmacol"},{"key":"4251_CR32","doi-asserted-by":"publisher","first-page":"7257681","DOI":"10.1155\/2018\/7257681","volume":"2018","author":"V Furer","year":"2018","unstructured":"Furer V, Hazan E, Mor A, Segal M, Katav A, Aloush V, Elkayam O, George J, Ablin JN (2018) Elevated levels of eotaxin-2 in serum of fibromyalgia patients. Pain Res Manag 2018:7257681. \n                    https:\/\/doi.org\/10.1155\/2018\/7257681","journal-title":"Pain Res Manag"},{"key":"4251_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00296-014-3172-2","volume":"35","author":"DJ Wallace","year":"2015","unstructured":"Wallace DJ, Gavin IM, Karpenko O, Barkhordar F, Gillis BS (2015) Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis. Rheumatol Int 35:991\u2013996. \n                    https:\/\/doi.org\/10.1007\/s00296-014-3172-2","journal-title":"Rheumatol Int"},{"key":"4251_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S128508","volume":"10","author":"E B\u00e4ckryd","year":"2017","unstructured":"B\u00e4ckryd E, Tanum L, Lind AL, Larsson A, Gordh T (2017) Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res 10:515\u2013525. \n                    https:\/\/doi.org\/10.2147\/JPR.S128508","journal-title":"J Pain Res"},{"key":"4251_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.psyneuen.2011.07.021","volume":"37","author":"A Geiss","year":"2012","unstructured":"Geiss A, Rohleder N, Anton F (2012) Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 37:671\u2013684. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2011.07.021","journal-title":"Psychoneuroendocrinology"},{"key":"4251_CR36","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49:1618\u20131631. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keq045","journal-title":"Rheumatology (Oxford)"},{"key":"4251_CR37","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s10067-017-3647-0","volume":"36","author":"S Akt\u00fcrk","year":"2017","unstructured":"Akt\u00fcrk S, B\u00fcy\u00fckavc\u0131 R (2017) Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clin Rheumatol 36:1885\u20131889. \n                    https:\/\/doi.org\/10.1007\/s10067-017-3647-0","journal-title":"Clin Rheumatol"},{"key":"4251_CR38","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.12669\/pjms.345.15169","volume":"34","author":"MSM Al-Nimer","year":"2018","unstructured":"Al-Nimer MSM, Mohammad TAM (2018) Correlation of hematological indices and ratios derived from them with FIQR scores in fibromyalgia. Pak J Med Sci 34:1219\u20131224. \n                    https:\/\/doi.org\/10.12669\/pjms.345.15169","journal-title":"Pak J Med Sci"},{"key":"4251_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7754\/Clin.Lab.2017.171024","volume":"64","author":"C Mertoglu","year":"2018","unstructured":"Mertoglu C, Gunay M, Yerligok O (2018) Could endocan, a marker of inflammation and endothelial dysfunction, be a new diagnostic marker for fibromyalgia? Clin Lab 64:405\u2013410. \n                    https:\/\/doi.org\/10.7754\/Clin.Lab.2017.171024","journal-title":"Clin Lab"},{"key":"4251_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/JPR.S71344","volume":"7","author":"JA Sturgeon","year":"2014","unstructured":"Sturgeon JA, Darnall BD, Zwickey HL, Wood LJ, Hanes DA, Zava DT, Mackey SC (2014) Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status. J Pain Res 7:707\u2013716. \n                    https:\/\/doi.org\/10.2147\/JPR.S71344","journal-title":"J Pain Res"},{"key":"4251_CR41","doi-asserted-by":"publisher","first-page":"627041","DOI":"10.1155\/2014\/627041","volume":"2014","author":"MI Bokarewa","year":"2014","unstructured":"Bokarewa MI, Erlandsson MC, Bjersing J, Dehlin M, Mannerkorpi K (2014) Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgia. Mediators Inflamm 2014:627041. \n                    https:\/\/doi.org\/10.1155\/2014\/627041","journal-title":"Mediators Inflamm"},{"key":"4251_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1590\/2359-3997000000248","volume":"61","author":"ES Paiva","year":"2017","unstructured":"Paiva ES, Andretta A, Batista ED, Lobo MMMT, Miranda RC, Nisihara R, Schieferdecker MEM, Boguszewski CL (2017) Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight\/obesity. Arch Endocrinol Metab 61:249\u2013256. \n                    https:\/\/doi.org\/10.1590\/2359-3997000000248","journal-title":"Arch Endocrinol Metab"},{"key":"4251_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/OARRR.S155919","volume":"10","author":"B Bordoni","year":"2018","unstructured":"Bordoni B, Marelli F, Morabito B, Cavallaro F, Lintonbon D (2018) Fascial preadipocytes: another missing piece of the puzzle to understand fibromyalgia? Open Access Rheumatol 10:27\u201332. \n                    https:\/\/doi.org\/10.2147\/OARRR.S155919","journal-title":"Open Access Rheumatol"},{"key":"4251_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.14744\/nci.2017.31644","volume":"5","author":"S Ataoglu","year":"2018","unstructured":"Ataoglu S, Ankarali H, Samanci R, Ozsahin M, Admis O (2018) The relationship between serum leptin level and disease activity and inflammatory markers in fibromyalgia patients N Clin Istanb 5:102\u2013108. \n                    https:\/\/doi.org\/10.14744\/nci.2017.31644","journal-title":"N Clin Istanb"},{"key":"4251_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1756-185X.12155","volume":"16","author":"SM Olama","year":"2013","unstructured":"Olama SM, Elsaid TO, El-Arman M (2013) Serum leptin in Egyptian patients with fibromyalgia syndrome: relation to disease severity. Int J Rheum Dis 16:583\u2013589. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12155","journal-title":"Int J Rheum Dis"},{"key":"4251_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1155\/2012\/350654","volume":"17","author":"JN Ablin","year":"2012","unstructured":"Ablin JN, Aronov N, Shimon I, Kanety H, Pariente C, Aloush V, Elkayam O, Levartovsky D (2012) Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controls. Pain Res Manag 17:89\u201392","journal-title":"Pain Res Manag"},{"key":"4251_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12944-017-0505-7","volume":"16","author":"N Stensson","year":"2017","unstructured":"Stensson N, Ghafouri B, Gerdle B, Ghafouri N (2017) Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain\u2014a case control study. Lipids Health Dis 16:112. \n                    https:\/\/doi.org\/10.1186\/s12944-017-0505-7","journal-title":"Lipids Health Dis"},{"key":"4251_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","volume":"125","author":"T McGarry","year":"2018","unstructured":"McGarry T, Biniecka M, Veale DJ, Fearon U (2018) Hypoxia, oxidative stress and inflammation. Free Radic Biol Med 125:15\u201324. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.03.042","journal-title":"Free Radic Biol Med"},{"key":"4251_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/1756-185X.12787","volume":"20","author":"A Fais","year":"2017","unstructured":"Fais A, Cacace E, Atzori L, Era B, Ruggiero V (2017) Plasma phospholipase, \u03b3-CEHC and antioxidant capacity in fibromyalgia. Int J Rheum Dis 20:550\u2013554. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12787","journal-title":"Int J Rheum Dis"},{"key":"4251_CR50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.bbadis.2015.03.005","volume":"1852","author":"E Alcocer-G\u00f3mez","year":"2015","unstructured":"Alcocer-G\u00f3mez E, Garrido-Maraver J, Bull\u00f3n P, Mar\u00edn-Aguilar F, Cot\u00e1n D, Carri\u00f3n AM, Alvarez-Suarez JM, Giampieri F, S\u00e1nchez-Alcazar JA, Battino M, Cordero MD (2015) Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from Fibromyalgia patients. Biochim Biophys Acta 1852:1257\u20131267. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2015.03.005","journal-title":"Biochim Biophys Acta"},{"key":"4251_CR51","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1089\/ars.2012.4892","volume":"18","author":"MD Cordero","year":"2013","unstructured":"Cordero MD, D\u00edaz-Parrado E, Carri\u00f3n AM, Alfonsi S, S\u00e1nchez-Alcazar JA, Bull\u00f3n P, Battino M, de Miguel M (2013) Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal 18:800\u2013807. \n                    https:\/\/doi.org\/10.1089\/ars.2012.4892","journal-title":"Antioxid Redox Signal"},{"key":"4251_CR52","doi-asserted-by":"publisher","first-page":"e107626","DOI":"10.1371\/journal.pone.0107626","volume":"9","author":"P Caboni","year":"2014","unstructured":"Caboni P, Liori B, Kumar A, Santoru ML, Asthana S, Pieroni E, Fais A, Era B, Cacace E, Ruggiero V, Atzori L (2014) Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia. PLoS One 9:e107626. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0107626","journal-title":"PLoS One"},{"key":"4251_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/ars.2014.6120","volume":"24","author":"P Bull\u00f3n","year":"2016","unstructured":"Bull\u00f3n P, Alcocer-G\u00f3mez E, Carri\u00f3n AM, Mar\u00edn-Aguilar F, Garrido-Maraver J, Rom\u00e1n-Malo L, Ruiz-Cabello J, Culic O, Ryffel B, Apetoh L, Ghiringhelli F, Battino M, S\u00e1nchez-Alcazar JA, Cordero MD (2016) AMPK phosphorylation modulates pain by activation of NLRP3 inflammasome. Antioxid Redox Signal 24:157\u2013170. \n                    https:\/\/doi.org\/10.1089\/ars.2014.6120","journal-title":"Antioxid Redox Signal"},{"key":"4251_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mito.2015.01.010","volume":"21","author":"B S\u00e1nchez -Dom\u00ednguez","year":"2015","unstructured":"S\u00e1nchez -Dom\u00ednguez B, Bull\u00f3n P, Rom\u00e1n-Malo L, Mar\u00edn-Aguilar F, Alcocer-G\u00f3mez E, Carri\u00f3n AM, S\u00e1nchez-Alcazar JA, Cordero MD (2015) Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with Fibromyalgia. Mitochondrion 21:69\u201375. \n                    https:\/\/doi.org\/10.1016\/j.mito.2015.01.010","journal-title":"Mitochondrion"},{"key":"4251_CR55","doi-asserted-by":"publisher","first-page":"e6130","DOI":"10.1097\/MD.0000000000006130","volume":"96","author":"B Gerdle","year":"2017","unstructured":"Gerdle B, Ghafouri B, Ghafouri N, B\u00e4ckryd E, Gordh T (2017) Signs of ongoing inflammation in female patients with chronic widespread pain: a multivariate, explorative, cross-sectional study of blood samples. Medicine (Baltimore) 96:e6130. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000006130","journal-title":"Medicine (Baltimore)"},{"key":"4251_CR56","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00393-013-1330-7","volume":"73","author":"S Halilo\u011flu","year":"2014","unstructured":"Halilo\u011flu S, Carlioglu A, Sahiner E, Karaaslan Y, Kosar A (2014) Mean platelet volume in patients with fibromyalgia. Z Rheumatol 73:742\u2013745. \n                    https:\/\/doi.org\/10.1007\/s00393-013-1330-7","journal-title":"Z Rheumatol"},{"key":"4251_CR57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12891-017-1641-y","volume":"18","author":"T Feinberg","year":"2017","unstructured":"Feinberg T, Sambamoorthi U, Lilly C, Innes KK (2017) Potential mediators between fibromyalgia and c-reactive protein: results from a large US Community Survey. BMC Musculoskelet Disord 18:294. \n                    https:\/\/doi.org\/10.1186\/s12891-017-1641-y","journal-title":"BMC Musculoskelet Disord"},{"key":"4251_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1573397111666150522095004","volume":"11","author":"SK Metyas","year":"2015","unstructured":"Metyas SK, Solyman JS, Arkfeld DG (2015) Inflammatory fibromyalgia: is it real? Curr Rheumatol Rev 11:15\u201317. \n                    https:\/\/doi.org\/10.2174\/1573397111666150522095004","journal-title":"Curr Rheumatol Rev"},{"key":"4251_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1099800415591035","volume":"18","author":"A Rus","year":"2016","unstructured":"Rus A, Molina F, Gass\u00f3 M, Camacho MV, Peinado M, del Moral ML (2016) Nitric oxide, inflammation, lipid profile, and cortisol in normal- and overweight women with fibromyalgia. Biol Res Nurs 18:138\u2013146. \n                    https:\/\/doi.org\/10.1177\/1099800415591035","journal-title":"Biol Res Nurs"},{"key":"4251_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger J, Noor N, McCue R, Mackey S (2013) Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 65:529\u2013538. \n                    https:\/\/doi.org\/10.1002\/art.37734","journal-title":"Arthritis Rheum"},{"key":"4251_CR61","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3390\/biomedicines5020016","volume":"5","author":"L Parkitny","year":"2017","unstructured":"Parkitny L, Younger J (2017) Reduced pro-inflammatory cytokines after 8\u00a0weeks of low-dose naltrexone for fibromyalgia. Biomedicines 5:E16. \n                    https:\/\/doi.org\/10.3390\/biomedicines5020016","journal-title":"Biomedicines"},{"key":"4251_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","volume":"4","author":"R Giorno Del","year":"2015","unstructured":"Del Giorno R, Skaper S, Paladini A, Varrassi G, Coaccioli S (2015) Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies. Pain Ther 4:169\u2013178. \n                    https:\/\/doi.org\/10.1007\/s40122-015-0038-6","journal-title":"Pain Ther"},{"key":"4251_CR63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, H\u00e4user W, Flu\u00df E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76:318\u2013328. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-209724","journal-title":"Ann Rheum Dis"},{"key":"4251_CR64","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jad.2011.11.016","volume":"136","author":"M Maes","year":"2012","unstructured":"Maes M, Ringel K, Kubera M, Berk M, Rybakowski J (2012) Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord 136:386\u2013392. \n                    https:\/\/doi.org\/10.1016\/j.jad.2011.11.016","journal-title":"J Affect Disord"},{"key":"4251_CR65","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jpain.2015.08.004","volume":"16","author":"BH Natelson","year":"2015","unstructured":"Natelson BH, Vu D, Mao X, Weiduschat N, Togo F, Lange G, Blate M, Kang G, Coplan JD, Shungu DC (2015) Effect of milnacipran treatment on ventricular lactate in fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Pain 16:1211\u20131219. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2015.08.004","journal-title":"J Pain"},{"key":"4251_CR66","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrrheum.2016.25","volume":"12","author":"A Vasquez","year":"2016","unstructured":"Vasquez A (2016) Neuroinflammation in fibromyalgia and CRPS is multifactorial. Nat Rev Rheumatol 12:242. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2016.25","journal-title":"Nat Rev Rheumatol"},{"key":"4251_CR67","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10067-012-2053-x","volume":"31","author":"MK Senna","year":"2012","unstructured":"Senna MK, Sallam RA, Ashour HS, Elarman M (2012) Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial. Clin Rheumatol 31:1591\u20131597. \n                    https:\/\/doi.org\/10.1007\/s10067-012-2053-x","journal-title":"Clin Rheumatol"},{"key":"4251_CR68","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10067-013-2280-9","volume":"32","author":"L Bettoni","year":"2013","unstructured":"Bettoni L, Bonomi FG, Zani V, Manisco L, Indelicato A, Lanteri P, Banfi G, Lombardi G (2013) Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients. Clin Rheumatol 32:1337\u20131345. \n                    https:\/\/doi.org\/10.1007\/s10067-013-2280-9","journal-title":"Clin Rheumatol"},{"key":"4251_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-017-3233-4","volume":"444","author":"T Maeda","year":"2018","unstructured":"Maeda T, Kudo Y, Horiuchi T, Makino N (2018) Clinical and anti-aging effect of mud-bathing therapy for patients with fibromyalgia. Mol Cell Biochem 444:87\u201392. \n                    https:\/\/doi.org\/10.1007\/s11010-017-3233-4","journal-title":"Mol Cell Biochem"},{"issue":"6 Suppl 79","key":"4251_CR70","first-page":"S111","volume":"31","author":"L Bazzichi","year":"2013","unstructured":"Bazzichi L, Da Valle Y, Rossi A, Giacomelli C, Sernissi F, Giannaccini G, Betti L, Ciregia F, Giusti L, Scarpellini P, Dell\u2019Osso L, Marazziti D, Bombardieri S, Lucacchini A (2013) A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79):S111\u2013S120","journal-title":"Clin Exp Rheumatol"},{"key":"4251_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12160-013-9513-7","volume":"46","author":"MC Davis","year":"2013","unstructured":"Davis MC, Zautra AJ (2013) An online mindfulness intervention targeting socioemotional regulation in fibromyalgia: results of a randomized controlled trial. Ann Behav Med 46:273\u2013284. \n                    https:\/\/doi.org\/10.1007\/s12160-013-9513-7","journal-title":"Ann Behav Med"},{"key":"4251_CR72","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3389\/fpsyg.2014.01572","volume":"5","author":"A Amutio","year":"2015","unstructured":"Amutio A, Franco C, P\u00e9rez-Fuentes Mde C, G\u00e1zquez JJ, Mercader I (2015) Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients. Front Psychol 5:1572. \n                    https:\/\/doi.org\/10.3389\/fpsyg.2014.01572","journal-title":"Front Psychol"},{"key":"4251_CR73","doi-asserted-by":"publisher","first-page":"e35677","DOI":"10.1371\/journal.pone.0035677","volume":"7","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cano-Garc\u00eda FJ, Alcocer-G\u00f3mez E, De Miguel M, S\u00e1nchez-Alc\u00e1zar JA (2012) Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement. PLoS One 7:e35677. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035677","journal-title":"PLoS One"},{"key":"4251_CR74","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/ars.2013.5198","volume":"20","author":"MD Cordero","year":"2014","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, Culic O, Carri\u00f3n AM, de Miguel M, D\u00edaz-Parrado E, P\u00e9rez-Villegas EM, Bull\u00f3n P, Battino M, S\u00e1nchez-Alcazar JA (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20:1169\u20131180. \n                    https:\/\/doi.org\/10.1089\/ars.2013.5198","journal-title":"Antioxid Redox Signal"},{"key":"4251_CR75","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.3390\/ijms160816981","volume":"16","author":"A S\u00e1nchez","year":"2015","unstructured":"S\u00e1nchez A, Calpena AC, Clares B (2015) Evaluating the oxidative stress in inflammation: role of melatonin. Int J Mol Sci 16:16981\u201317004. \n                    https:\/\/doi.org\/10.3390\/ijms160816981","journal-title":"Int J Mol Sci"},{"key":"4251_CR76","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2050-6511-15-40","volume":"15","author":"SA Zanette de","year":"2014","unstructured":"de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, Xavier F, de Souza IC, Deitos A, Torres IL, Caumo W (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15:40. \n                    https:\/\/doi.org\/10.1186\/2050-6511-15-40","journal-title":"BMC Pharmacol Toxicol"},{"key":"4251_CR77","doi-asserted-by":"publisher","first-page":"e0127012","DOI":"10.1371\/journal.pone.0127012","volume":"10","author":"S Efrati","year":"2015","unstructured":"Efrati S, Golan H, Bechor Y, Faran Y, Daphna-Tekoah S, Sekler G, Fishlev G, Ablin JN, Bergan J, Volkov O, Friedman M, Ben-Jacob E, Buskila D (2015) Hyperbaric oxygen therapy can diminish fibromyalgia syndrome-prospective clinical trial. PLoS One 10:e0127012. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0127012","journal-title":"PLoS One"},{"key":"4251_CR78","doi-asserted-by":"publisher","first-page":"R162","DOI":"10.1186\/ar3902","volume":"14","author":"JL Bjersing","year":"2012","unstructured":"Bjersing JL, Dehlin M, Erlandsson M, Bokarewa MI, Mannerkorpi K (2012) Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides. Arthritis Res Ther 14:R162. \n                    https:\/\/doi.org\/10.1186\/ar3902","journal-title":"Arthritis Res Ther"},{"key":"4251_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12891-017-1477-5","volume":"18","author":"JL Bjersing","year":"2017","unstructured":"Bjersing JL, Larsson A, Palstam A, Ernberg M, Bileviciute-Ljungar I, L\u00f6fgren M, Gerdle B, Kosek E, Mannerkorpi K (2017) Benefits of resistance exercise in lean women with fibromyalgia: involvement of IGF-1 and leptin. BMC Musculoskelet Disord 18:106. \n                    https:\/\/doi.org\/10.1186\/s12891-017-1477-5","journal-title":"BMC Musculoskelet Disord"},{"key":"4251_CR80","doi-asserted-by":"publisher","first-page":"e74524","DOI":"10.1371\/journal.pone.0074524","volume":"8","author":"ME Bote","year":"2013","unstructured":"Bote ME, Garcia JJ, Hinchado MD, Ortega E (2013) Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise. PLoS One 8:e74524. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0074524","journal-title":"PLoS One"},{"key":"4251_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jneuroim.2014.10.003","volume":"277","author":"B Torgrimson-Ojerio","year":"2014","unstructured":"Torgrimson-Ojerio B, Ross RL, Dieckmann NF, Avery S, Bennett RM, Jones KD, Guarino AJ, Wood LJ (2014) Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia. J Neuroimmunol 277:160\u2013167. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2014.10.003","journal-title":"J Neuroimmunol"},{"key":"4251_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbi.2013.11.009","volume":"39","author":"ME Bote","year":"2014","unstructured":"Bote ME, Garc\u00eda JJ, Hinchado MD, Ortega E (2014) An exploratory study of the effect of regular aquatic exercise on the function of neutrophils from women with fibromyalgia: role of IL-8 and noradrenaline. Brain Behav Immun 39:107\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2013.11.009","journal-title":"Brain Behav Immun"},{"key":"4251_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1600-0838.2010.01132.x","volume":"22","author":"E Ortega","year":"2012","unstructured":"Ortega E, Bote ME, Giraldo E, Garc\u00eda JJ (2012) Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports 22:104\u2013112. \n                    https:\/\/doi.org\/10.1111\/j.1600-0838.2010.01132.x","journal-title":"Scand J Med Sci Sports"},{"key":"4251_CR84","doi-asserted-by":"publisher","first-page":"3985154","DOI":"10.1155\/2018\/3985154","volume":"2018","author":"M Ernberg","year":"2018","unstructured":"Ernberg M, Christidis N, Ghafouri B, Bileviciute-Ljungar I, L\u00f6fgren M, Bjersing J, Palstam A, Larsson A, Mannerkorpi K, Gerdle B, Kosek E (2018) Plasma Cytokine levels in fibromyalgia and their response to 15\u00a0weeks of progressive resistance exercise or relaxation therapy. Mediators Inflamm 2018:3985154. \n                    https:\/\/doi.org\/10.1155\/2018\/3985154","journal-title":"Mediators Inflamm"},{"key":"4251_CR85","doi-asserted-by":"publisher","first-page":"e6775","DOI":"10.1590\/1414-431X20176775","volume":"51","author":"VGC Ribeiro","year":"2018","unstructured":"Ribeiro VGC, Mendon\u00e7a VA, Souza ALC, Fonseca SF, Camargos ACR, Lage VKS, Neves CDC, Santos JM, Teixeira LAC, Vieira ELM, Teixeira Junior AL, Mez\u00eancio B, Fernandes JSC, Leite HR, Poortmans JR, Lacerda ACR (2018) Inflammatory biomarkers responses after acute whole body vibration in fibromyalgia. Braz J Med Biol Res 51:e6775. \n                    https:\/\/doi.org\/10.1590\/1414-431X20176775","journal-title":"Braz J Med Biol Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04251-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:05:01Z","timestamp":1581534301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04251-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04251-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"28 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that she has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}